Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age | medRxiv
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada | medRxiv
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
How Effective Are the Bivalent Boosters? CDC Shares New Data
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
Studies show real-world usefulness of bivalent COVID boosters | CIDRAP
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION - CROI Conference
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
NEJM on X: "Figure 1. Effectiveness of Bivalent Boosters According to the Interval since Administration. https://t.co/hIVtIujZoq #Covid19 https://t.co/KBljA6y7NR" / X
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
A quick update on the bivalent boosters - by Eric Topol
Bivalent mRNA booster effective, 'essential' for older adults
FDA clears the way for additional bivalent boosters for certain vulnerable individuals | CNN
Updated COVID boosters give significant protection, data show - Los Angeles Times
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ